Shares ofAnika Therapeutics Inc(NASDAQ:ANIK), a small-cap biotech focused on regenerativemedicine, were down 36% as of 11:10 a.m. EDT on Tuesday. The stock plummetedafter the company reported data from an important phase 3 study.
Headlines about Spherix (NASDAQ:SPEX) have been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies negative and positive press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale
iPass (NASDAQ:IPAS) reached a new 52-week high and low during mid-day trading on Friday . The company traded as low as $0.25 and last traded at $0.26, with a volume of 1008220 shares changing hands. The stock had previously closed at $0.27.
IPAS has been the subject of a number of analyst reports. Maxim Group set a $2.00 price target on iPass and gave the company a “buy” rating....More>>>
Rockwell Collins, Inc. (NYSE:COL) will be acquired by United Technologies Corporation (NYSE:UTX) in a $23 billion cash and stock deal. The transaction prices COL stock at $140 a share, an 18% premium to where it traded last month when the deal initially made news.
In what will be the biggest aerospace deal in history, industry watchers expect it to reshape....More>>>
"Sell everything," came the phone call on a January 1981 night… A crash was coming. The next morning, stocks dropped 2.5%. The market headed in that direction for most of the year, losing 9.7%. It was masterful crystal-ball gazing by market commentator Joe Granville. He would later say: "The market told me, 'Sell.' And we do what the market tells us to;....More>>>
Most businesses posting rapid expansion right now will not be able to maintain that level of growth over time. On the other hand, there will be standouts — the rare companies with the right makeup and competitive advantages to capitalize on market trends and repeatedly take their businesses to the next level.
Having even a few of these companies working in your favor over the long term....More>>>
The management of regulatory affairs essentially contributes to the overall success of new drug development – both at early pre-marketing stages and at all times post-marketing. This means that a biotech or pharma company’s regulatory affairs personnel will be heavily involved in all stages of new drug development both prior to and after an FDA approval.
United Technologies Co. (NYSE:UTX) has been given a consensus recommendation of “Buy” by the twenty research firms that are covering the stock, Marketbeat.com reports. Seven analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Th
Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp increased its stake in Western Digital Corp (NASDAQ:WDC) by 17.3% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund o
Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp increased its stake in Western Digital Corp (NASDAQ:WDC) by 17.3% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund ow
Over the past week, the Dow Jones Industrial Average has fallen by nearly 700 points, mainly fueled by fears of a global trade war. And there's no reason to think the volatility will subside anytime soon.
However, instead of panicking, it's important to take a step back and assess the si